JamesKPolkEsq

JamesKPolkEsq t1_it9pdrg wrote

CAR-T was once a headline, now is an incredible tool to fight hemotological malignancies that are highly treatment resistant.

PD-1 inhibitors were once a headline, now have changed the face of melanoma therapy.

Many oncology approaches don't work, some do.

22